These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22900912)

  • 1. Highly different risk estimates for atypical femoral fracture with use of bisphosphonates - debate must be allowed!
    Rydholm A
    Acta Orthop; 2012 Aug; 83(4):319-20. PubMed ID: 22900912
    [No Abstract]   [Full Text] [Related]  

  • 2. Retrospective review of patients with atypical bisphosphonate related proximal femoral fractures.
    Phillips HK; Harrison SJ; Akrawi H; Sidhom SA
    Injury; 2017 Jun; 48(6):1159-1164. PubMed ID: 28410753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonate-associated atypical femur fracture in a 90-year-old Caucasian woman.
    Gopinath KG; Shibu PK
    Hong Kong Med J; 2015 Jun; 21(3):286.e2-3. PubMed ID: 26045077
    [No Abstract]   [Full Text] [Related]  

  • 4. Can long-term bisphosphonate use causes low-energy fractures? A case report.
    Dandinoğlu T; Akarsu S; Karadeniz M; Tekin L; Arıbal S; Kıralp MZ
    Osteoporos Int; 2014 Feb; 25(2):773-6. PubMed ID: 23824297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical femoral fracture.
    Khan AA; Kaiser S
    CMAJ; 2017 Apr; 189(14):E542. PubMed ID: 28396331
    [No Abstract]   [Full Text] [Related]  

  • 6. Atypical femoral shaft fracture in a patient with non-metastatic prostate cancer on zoledronic acid therapy: effect of therapy or coincidence?
    Reddy SV; Gupta SK
    Singapore Med J; 2012 Mar; 53(3):e52-4. PubMed ID: 22434305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diphosphonate treatment of osteoporosis and risk of atypical femoral fractures].
    Schwarz P
    Ugeskr Laeger; 2012 Jan; 174(1-2):30. PubMed ID: 22233716
    [No Abstract]   [Full Text] [Related]  

  • 8. Low-energy femoral fractures associated with the long-term use of bisphosphonates: a case series from a Swiss university hospital.
    Ing-Lorenzini K; Desmeules J; Plachta O; Suva D; Dayer P; Peter R
    Drug Saf; 2009; 32(9):775-85. PubMed ID: 19670917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATYPICAL FEMORAL FRACTURES AFTER LONG-TERM BISPHOSPHONATES THERAPY: CASE REPORT.
    Găleşanu C; Mocanu V; Buzdugă C; Florescu A; Zaharia V; Lisnic V
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(1):114-8. PubMed ID: 27125082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical femoral fractures as an incidental finding on dual X-ray absorptiometry.
    Powrie N; Ismail A
    Rheumatology (Oxford); 2015 Feb; 54(2):218. PubMed ID: 25477055
    [No Abstract]   [Full Text] [Related]  

  • 11. Incidence, risk factors, and fracture healing of atypical femoral fractures: a multicenter case-control study.
    Lim SJ; Yeo I; Yoon PW; Yoo JJ; Rhyu KH; Han SB; Lee WS; Song JH; Min BW; Park YS
    Osteoporos Int; 2018 Nov; 29(11):2427-2435. PubMed ID: 30039251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Teriparatide treatment in an adult patient with hypophosphatasia exposed to bisphosphonate and revealed by bilateral atypical fractures.
    Righetti M; Wach J; Desmarchelier R; Coury F
    Joint Bone Spine; 2018 May; 85(3):365-367. PubMed ID: 29246529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 5-year follow-up of a cortical stress fracture resulting in a spontaneous atypical subtrochanteric femoral fracture in a female patient with severe osteoporosis and bisphosphonate therapy over 15 years.
    Haschka J; Kühne F; Muschitz C; Pirker T; Kocijan R; Bittighofer C; Trubrich A; Resch H
    Wien Klin Wochenschr; 2011 Nov; 123(21-22):684-7. PubMed ID: 21837437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Questioning the association between bisphosphonates and atypical femoral fractures.
    Pazianas M; Kim SM; Yuen T; Sun L; Epstein S; Zaidi M
    Ann N Y Acad Sci; 2015 Jan; 1335(1):1-9. PubMed ID: 25294742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes between older adults with atypical and typical femoral fractures are comparable.
    Khow KS; Paterson F; Shibu P; Yu SC; Chehade MJ; Visvanathan R
    Injury; 2017 Feb; 48(2):394-398. PubMed ID: 27839798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural history of incomplete atypical femoral fractures in patients after a prolonged and variable course of bisphosphonate therapy-a long-term radiological follow-up.
    Png MA; Mohan PC; Koh JSB; Howe CY; Howe TS
    Osteoporos Int; 2019 Dec; 30(12):2417-2428. PubMed ID: 31435684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical bilateral femoral shaft fracture in patient treated with bisphosphonates.
    Parrón Cambero R; Rey López A; Tomé-Bermejo F; Cibantos Martínez R
    Eur J Orthop Surg Traumatol; 2013 Nov; 23 Suppl 2():S219-23. PubMed ID: 23412218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical femoral fractures and bisphosphonate treatment: experience in two large United Kingdom teaching hospitals.
    Thompson RN; Phillips JR; McCauley SH; Elliott JR; Moran CG
    J Bone Joint Surg Br; 2012 Mar; 94(3):385-90. PubMed ID: 22371548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonates in osteoporosis: NICE and easy?
    Harvey NC; McCloskey E; Kanis JA; Compston J; Cooper C
    Lancet; 2017 Nov; 390(10109):2243-2244. PubMed ID: 29165263
    [No Abstract]   [Full Text] [Related]  

  • 20. [Atypical fractures of the femur: apropos of 3 clinical cases].
    Sanduloviciu M; Stoll D; Lamy O; Krieg MA; Aubry-Rozier B
    Praxis (Bern 1994); 2014 Aug; 103(16):939-44. PubMed ID: 25097162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.